Nature Medicine, Published online: 03 April 2026; doi:10.1038/s41591-026-04305-w To accelerate therapeutic development and equip stakeholders with clear benchmarks, the authors outline target product profiles for therapies designed to delay or prevent the onset of clinical symptoms of Alzheimer’s disease.
Nature Medicine published a clinical update in Research Highlights on 03 Apr 2026.
The item focuses on Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease.
Review the original article for the full source wording and details.